Home / Therapies / Insulin Therapy Center (page 30)

Insulin Therapy Center

Insulin Therapy for Diabetes: Diabetes in Control answers key questions about the uses and challenges of insulin in diabetes management, including:
– How insulin is used to treat diabetes
– How/when a healthcare professional should consider insulin therapy for diabetes patients
– What a healthcare professional needs to know about making insulin therapy safe and effective

Vibe Insulin Pump with CGMS Technology

  Animas, a division of Johnson & Johnson, has finally won FDA approval for its Vibe insulin pump and continuous glucose monitoring system. The pump is the first to pair with Dexcom’s G4 PLATINUM continuous glucose monitor that samples interstitial fluid every five minutes and provides a trending chart of …

Read More »

Increased Mortality with Combining Sulfonylurea and Insulin

About 11,000 patients using both insulin and sulfonylurea were evaluated… Ulrik M. Mogensen, MD, of the department of cardiology at University Hospital Rigshospitalet in Denmark, and colleagues evaluated patients receiving sulfonylurea with insulin and 16,910 patients receiving metformin with insulin to determine the differences in outcomes of treatment combinations. Outcome …

Read More »

Early Insulin Therapy Makes an Impact

Improved glycemic control can reduce A1c, medical costs and complications… According to a new study, early introduction of insulin could save money, help more patients reach A1c goals and decrease diabetes-related complications and mortality. Currently, insulin therapy for persons with type 2 diabetes is traditionally added to an anti-hyperglycemic regimen …

Read More »

Remote Wireless Monitoring Can Help Patients Newly Diagnosed with T1

A patient of mine was newly diagnosed with type 1 diabetes. He started on insulin and I taught him about glucose targets; insulin administration, including the signs and symptoms of hypoglycemia; and how to prevent, recognize, and treat hypoglycemia. I also taught him about the “honeymoon period,” which, I told …

Read More »

DPP-4 Inhibitors in Combination with Insulin Therapy for Type 2 Diabetes Patients

The addition of a DPP-4 inhibitor decreased HbA1C while not requiring an increase in insulin, and subjects remained weight neutral without experiencing an increase in hypoglycemic events… Currently approved dipeptidyl peptidase-4 (DPP-4) inhibitors include alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin. DPP-4 inhibitors work by enhancing glucose dependent insulin secretion and …

Read More »